Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China · Delayed Price · Currency is CNY 11.87
+0.46 (4.03%)
Apr 9, 2026, 3:12 PM CST
SHE:300485 Revenue
In the year 2025, Beijing Science Sun Pharmaceutical had annual revenue of 404.72M CNY, down -2.82%. Beijing Science Sun Pharmaceutical had revenue of 96.09M in the quarter ending December 31, 2025, with 2.66% growth.
Revenue
404.72M
Revenue Growth
-2.82%
P/S Ratio
14.13
Revenue / Employee
788.92K
Employees
513
Market Cap
5.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 404.72M | -11.76M | -2.82% |
| Dec 31, 2024 | 416.48M | -60.09M | -12.61% |
| Dec 31, 2023 | 476.57M | -257.98M | -35.12% |
| Jan 1, 2023 | 734.55M | -316.26M | -30.10% |
| Jan 1, 2022 | 1.05B | -43.42M | -3.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ZhuZhou QianJin Pharmaceutical Co.,Ltd | 3.63B |
| Jianmin Pharmaceutical Group | 3.37B |
| Luoxin Pharmaceuticals Group Stock | 2.49B |
| Tianjin Lisheng Pharmaceutical | 1.39B |
| Beijing Beilu Pharmaceutical | 1.13B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| ChengDu ShengNuo Biotec | 741.34M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 619.88M |